NCT03827668 - A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

April 29, 2019

Study Completion Date

April 29, 2019

Conditions

Healthy

Interventions

DRUG

PF-06650833 alone

In Period 1, Days 1-5, participants will receive PF-06650833 once daily alone.

DRUG

PF-06651600 alone

In Period 2, Days 1-7, participants will receive PF-06651600 once daily alone.

DRUG

PF-06650833 together with PF-06651600

In Period 2, Days 8-12, participants will receive PF-06650833 once daily together with PF-06650833 once daily.

Trial Locations (1)

Pfizer New Haven Clinical Research Unit, New Haven